› $150,000,000 verdict in personal injury case
The Epilepsy Foundation is warning people who take Dilantin or Lamictal to control their seizures that the medications can cause users to suffer from a rare but serious skin condition known as Stevens Johnson Syndrome (SJS).
The Centers for Disease Control (CDC) is warning the public about a medication used to treat a type of glaucoma because users could develop a serious and life threatening allergic reaction known as Stevens Johnson Syndrome (SJS). Neptazane (methazolamide) is a sulfonamide derivative available as 25 mg and 50 mg tablets used in the treatment of an eye condition called open-angle glaucoma. This type of glaucoma is caused by a gradual blockage of the outflow of fluid in the front compartment of the eye over a period of years, causing a slow rise in pressure. It is also used in the type called acute angle-closure glaucoma, when pressure within the eye must be lowered before surgery. The medication should not be used for any other type of glaucoma.
When Kelly Samson of Toledo, Ohio, first noticed spots breaking out on her daughter’s skin, she assumed her daughter had come down with the chickenpox. She was wrong. The young girl was diagnosed with something far more serious, a serious skin reaction known as Stevens Johnson Syndrome (SJS).
More than 2,000 drugs, including penicillin, antibiotics, some epilepsy drugs and anti-inflammatory drugs including popular OTC brands Advil, Aleve and Motrin, have been linked to a rare but life threatening allergic reaction to medicine known as Stevens Johnson Syndrome (SJS). When people first present symptoms of the condition, they are most often misdiagnosed until the patient’s health worsens. Though rare, some cases can be fatal. Which is why it is important to understand SJS and recognize its symptoms so that medical attention can be sought early.
My son was 2.5 years old when he was admitted to the Children’s Hospital on Nov 7th, 2009, in Winnipeg, MB Canada. I also had never heard of SJS. Today, it is all I think about.
The mother of young Liam refers to herself simply as Melanie. But she so identified with Avi Selk’s recent Dallas Morning News story about a rare skin condition known as Stevens Johnson Syndrome, or SJS, that she felt compelled to comment on the story.
A medicine used to treat and help prevent the flu may put patients at risk for a rare but life-threatening condition in which the skin peels off the body in sheets, according to the Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research. The agency notified the public that it has approved safety label changes for Relenza (zanamivir) Inhalation Powder for oral inhalation. The Adverse Reactions section of the drug’s new safety label now includes a risk of rash, including serious cutaneous reactions (e.g. erythema multiforme, Stevens Johnson Syndrome, SJS, and toxic epidermal necrolysis, TEN).
